Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis
article
OA: bronze
CC0
⤵ 34 in-corpus citations
AI-generated summary
This study investigated the effects of aromatase inhibitors on the proliferation and apoptosis of endometrial cell cultures derived from patients diagnosed with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo study the effect of letrozole (Let) and anastrozole (Anas) on apoptosis and cell proliferation in epithelial endometrial cells (EEC) from patients with endometriosis (EDT).DesignProspective study.SettingResearch institute and clinical fertility center.Patient(s)Eighteen women with untreated EDT.Intervention(s)Biopsy specimens of eutopic endometrium were obtained from all subjects. Apoptosis and cell proliferation were examined in EEC after incubation with Let or Anas.Main outcome measure(s)Percentage of apoptotic cells (ApC) was evaluated by the acridine orange-ethidium bromide technique; cell proliferation was assessed by 3H-thymidine incorporation.Result(s)Treatment with Let 10 nM and Let 100 nM enhanced values of ApC in cultures from EDT patients. Epithelial endometrial cells treated with Anas 100 nM or Anas 500 nM showed a statistically significant induction on apoptosis levels. Cultures treated with Let 1 nM or Anas 50 nM did not show any significant differences in ApC levels compared with basal conditions. 3H-Thymidine uptake was down regulated by Let 10 nM and Let 100 nM. Similarly, Anas 100 nM and Anas 500 nM showed a significantly lower degree of cell proliferation in EEC. Lower concentrations of Let and Anas did not induce any significant change in cell proliferation rates.Conclusion(s)Our results show that Let and Anas produced a significant and positive effect on apoptosis and cell proliferation on EEC from EDT patients. These findings support the further investigation of aromatase inhibitors as a treatment option in EDT.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target via openalex
- Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis via openalex
- Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In Vitro via openalex
- Effect of peritoneal fluid from patients with mild and severe endometriosis on endometrial stromal cell proliferation via openalex
- Endometrial Anomalies in Women with Endometriosis via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance via openalex
- Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue via openalex
- Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis via openalex
- Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis via openalex
- Steroid receptor and aromatase expression in baboon endometriotic lesions via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman via openalex
- W6637280862 via openalex
- W2076112248 via openalex
- W2077646258 via openalex
- W2111226394 via openalex
- W2159803441 via openalex
- W2166744769 via openalex
- W2173390200 via openalex
- W2275699845 via openalex
- W2477008945 via openalex
- W1671912264 via openalex
Cited by (35)
- Additional file 1 of Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy 2024
- Additional file 1 of Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy 2024
- Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy 2023
- The Effects of Lapatinib and Trastuzumab in a Rat Model of Endometriosis 2022
- Medical and Surgical Management of Endometriosis 2018
- Analysis of Gene Expression in the Endocervical Epithelium of Wonnen With Deep Endometriosis 2016
- Effect of imatinib on growth of experimental endometriosis in rats 2016
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
- Effects of cisplatin and letrozole on surgically induced endometriosis and comparison of the two medications in a rat model 2016
- Apoptosis in Endometriosis 2014
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Comparison of antiproliferative effects of metformine and progesterone on estrogen-induced endometrial hyperplasia in rats 2013
- Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? 2013
- New trends for the medical treatment of endometriosis 2012
- Hormonal strategy for the primary or secondary treatment of endometriosis 2012
- Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? 2012
- Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis 2012
- Involvement of Prostaglandins in the Pathophysiology of Endometriosis 2012
- Aromatase inhibitors in post-menopausal endometriosis 2011
- [Relevance of apoptosis in the female reproductive system]. 2011
- The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model 2011
- Apoptosis and bcl-2 expression in ectopic endometrium of patient with endometriosis 2011
- Treatment of Endometriosis and Chronic Pelvic Pain with Letrozole and Norethindrone Acetate 2010
- Apoptosis and endometriosis 2010
- Traitement de l’endométriose par les inhibiteurs de l’aromatase : efficacité thérapeutique et conséquences osseuses 2010
- The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model 2010
- Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo 2010
- Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis 2009
- Involvement of resistance to apoptosis in the pathogenesis of endometriosis. 2009
- Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis 2008
- Dysmenorrhea in Adolescents 2008
- Selective Estrogen-Receptor Modulators and Aromatase Inhibitors: Promising New Medical Therapies for Endometriosis? 2007
- Apoptosis and endometriosis 2007
- Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle 2006
- Investigational drugs for endometriosis 2006
Source provenance
- europepmc
- last seen: 2026-08-01T06:07:04.264727+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:35.797702+00:00
License: CC0
· commercial use OK